Status:
COMPLETED
Implantable Cardioverter Defibrillator (ICD) Patients and Inhalation Aromatherapy
Lead Sponsor:
TC Erciyes University
Collaborating Sponsors:
The Scientific and Technological Research Council of Turkey
Conditions:
Implantable Cardioverter Defibrillator (ICD)
Aromatherapy
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The effective management of anxiety and fatigue, which lead to negative physical, social, and psychological impacts and increase treatment costs in individuals with implanted cardioverter-defibrillato...
Eligibility Criteria
Inclusion
- Individuals who were willing to participate in the study,
- aged between 18 and 65 years,
- with no physical or mental health issues that would hinder communication,
- had an ICD implanted at least 6 months ago,
- had a battery life of at least 3 months,
- had a fatigue level of 3 or higher on the Visual Analog Scale for Fatigue (VAS-F),
- had an EF of 40% or higher,
- and were visiting the cardiology outpatient clinic for ICD control
Exclusion
- Individuals receiving anxiolytic or antidepressant treatment,
- those with respiratory system diseases (such as asthma, bronchitis, or chronic obstructive pulmonary disease), 19,231 characters left
- those with a known sensitivity to the essential oils used, and individuals with an olfactory impairment
Key Trial Info
Start Date :
September 8 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 15 2025
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT06874777
Start Date
September 8 2023
End Date
February 15 2025
Last Update
March 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Turkish Ministry of Health, Adana City Training and Research Hospital
Adana, Yüreğir, Turkey (Türkiye), 4522